As we announced before, Ajinomoto Bio-Pharma Services Osaka adopted the new email address domain on November 9 last year.
We have been able to receive emails addressed to the previous domain ( @genedesign.co.jp ) for a year, however, now it has turned to be impossible to receive them.
We apologize for the inconvenience, but kindly ask you to send your emails to our new domain ( @jp.ajibio-pharma.com ).